CoChat

Allopurinol Acutely Increases Adenosine Triphospate Energy Delivery in Failing Human Hearts

Open access
Hirsch, Glenn A., Bottomley, Paul A., Gerstenblith, Gary, Weiss, Robert G. · 2012 · Journal of the American College of Cardiology
Cited by 105

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Objectives We tested the hypothesis that acute administration of the XO inhibitor, allopurinol, improves cardiac high-energy phosphate concentrations in human HF and increases the rate of ATP synthesis through creatine kinase (CK), the primary myocardial energy reserve. Background Studies of patients and animal models implicate impaired myocardial high-energy phosphate availability in heart failure (HF). The xanthine oxidase (XO) reaction is a critical terminal step in ATP and purine degradation and an important source of reactive oxygen species. Thus, XO inhibition is a potentially attractive means to improve energy metabolism in the failing human heart. Methods We randomized 16 patients with non-ischemic cardiomyopathy in a double-blind fashion to allopurinol (300 mg IV) or placebo infusion, 4:1, the latter for purposes of blinding only. The myocardial concentrations of adenosine triphosphate (ATP) and creatine phosphate (PCr) and the rate of ATP synthesis through CK (CK flux) were determined by 31P magnetic resonance spectroscopy. Results Allopurinol infusion increased mean cardiac PCr/ATP and [PCr] by ~11% (P < 0.02), and mean CKs flux by 39% (2.07 ± 1.27 μmol/g/s to 2.87 ± 1.82 μmol/g/s, p < 0.007). Calculated cytosolic [ADP] declined while the free energy of ATP hydrolysis (ΔG~ATP) increased with allopurinol. The increased CK flux was disproportionate to substrate changes, indicating increased CK enzyme activity. Conclusions Intravenous administration of the XO inhibitor, allopurinol, acutely improves the relative and absolute concentrations of myocardial high-energy phosphates and ATP flux through CK in the failing human heart, offering direct evidence that myofibrillar CK energy delivery can be pharmaceutically-augmented in the failing human heart.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2011.10.895

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 31

  1. Ingwall, 1993, Is cardiac failure a consequence of decreased energy reserve?, Circulation, 87, VII 58
  2. Katz, 1998, Is the failing heart energy depleted?, Cardiol Clin, 16, 633, 10.1016/S0733-8651(05)70040-0 · DOI
  3. George, 2009, Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress, Vasc Health Risk Manag, 5, 265, 10.2147/VHRM.S4265 · DOI · Paper page
  4. Nascimben, 1996, Creatine kinase system in failing and nonfailing human myocardium, Circulation, 94, 1894, 10.1161/01.CIR.94.8.1894 · DOI · Paper page
  5. Mekhfi, 1996, Creatine kinase is the main target of reactive oxygen species in cardiac myofibrils, Circ Res, 78, 1016, 10.1161/01.RES.78.6.1016 · DOI
  6. Hou, 2006, Acute effects of Febuxostat, a nonpurine selective inhibitor of xanthine oxidase, in pacing induced heart failure, J Cardiovasc Pharmacol, 48, 255, 10.1097/01.fjc.0000249961.61451.da · DOI
  7. Ekelund, 1999, Intravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efficiency in dogs with pacing-induced heart failure, Circ Res, 85, 437, 10.1161/01.RES.85.5.437 · DOI · Paper page
  8. Hardy, 1991, Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy, Am Heart J, 122, 795, 10.1016/0002-8703(91)90527-O · DOI · Paper page
  9. Conway, 1991, Detection of low phosphocreatine to ATP ratio in failing hypertrophied human myocardium by 31P magnetic resonance spectroscopy, Lancet, 338, 973, 10.1016/0140-6736(91)91838-L · DOI · Paper page
  10. Neubauer, 1992, 31P Magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease: altered cardiac high-energy phosphate metabolism in heart failure, Circulation, 86, 1810, 10.1161/01.CIR.86.6.1810 · DOI · Paper page
  11. Weiss, 2005, ATP flux through creatine kinase in the normal, stressed, and failing human heart, Proc Natl Acad Sci U S A, 102, 808, 10.1073/pnas.0408962102 · DOI · Paper page
  12. Bottomley, 2009, Reduced myocardial creatine kinase flux in human myocardial infarction: an in vivo phosphorus magnetic resonance spectroscopy study, Circulation, 119, 1918, 10.1161/CIRCULATIONAHA.108.823187 · DOI
  13. Naumova, 2006, Xanthine oxidase inhibitors improve energetics and function following infarction in the failing mouse heart, Am J Physiol, 290, H837
  14. Bottomley, 2002, The four-angle saturation transfer (FAST) method for measuring creatine kinase reaction rates in vivo, Mag Res Med, 47, 850, 10.1002/mrm.10130 · DOI · Paper page
  15. Gabr, 2008, Correcting reaction rates measured by saturation-transfer magnetic resonance spectroscopy, J Magn Reson, 191, 248, 10.1016/j.jmr.2007.12.015 · DOI
  16. Gibbs, 1985, The cytoplasmic phosphorylation potential, J Mol Cell Cardiol, 17, 727, 10.1016/S0022-2828(85)80034-1 · DOI
  17. Bittl, 1987, Rate equation for creatine kinase predicts the in vivo reaction velocity: 31P NMR surface coil studies in brain, heart and skeletal muscle of the living rat, Biochemistry, 26, 6083, 10.1021/bi00393a021 · DOI · Paper page
  18. Schaefer, 1992, Metabolic response of the human heart to inotropic stimulation: in vivo phosphorus-31 studies of normal and cardiomyopathic myocardium, Magn Reson Med, 25, 260, 10.1002/mrm.1910250205 · DOI
  19. Neubauer, 1997, Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy, Circulation, 96, 2190, 10.1161/01.CIR.96.7.2190 · DOI · Paper page
  20. Tian, 1996, Energetic basis for reduced contractile reserve in isolated rat hearts, Am J Physiol, 270, H1207
  21. Tian, 1997, Failure to maintain a low ADP concentration impairs diastolic function in hypertrophied rat hearts, Circulation, 96, 1313, 10.1161/01.CIR.96.4.1313 · DOI · Paper page
  22. Lasley, 1988, Allopurinol enhanced adenine nucleotide repletion after myocardial ischemia in the isolated rat heart, J Clin Invest, 81, 16, 10.1172/JCI113288 · DOI · Paper page
  23. Shen, 1999, Progressive loss of myocardial ATP due to a loss of total purines during the development of heart failure in dogs: a compensatory role for the parallel loss of creatine, Circulation, 100, 2113, 10.1161/01.CIR.100.20.2113 · DOI · Paper page
  24. George, 2008, The OPT-CHF (oxypurinol threrapy for congestive heart failure) trial: a question of dose, J Am Coll Cardiol, 53, 2405, 10.1016/j.jacc.2008.07.076 · DOI
  25. Thanassoulis, 2010, Gout, allopurinol use, and heart failure outcomes, Arch Intern Med, 170, 1358, 10.1001/archinternmed.2010.198 · DOI · Paper page
  26. Blain, 1956, Studies on myocardial metabolism, Am J Med, 20, 820, 10.1016/0002-9343(56)90203-0 · DOI · Paper page
  27. Sodi-Pallares, 1962, Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction, Am J Cardiol, 9, 166, 10.1016/0002-9149(62)90035-8 · DOI · Paper page
  28. Opie, 2009, The adrenergic-fatty acid load in heart failure, J Am Coll Cardiol, 54, 1637, 10.1016/j.jacc.2009.07.024 · DOI
  29. Soukoulis, 2009, Micronutrient deficiencies an unmet need in heart failure, J Am Coll Cardiol, 54, 1660, 10.1016/j.jacc.2009.08.012 · DOI
  30. Liao, 2003, Cardiac-specific overexpression of GLUT1 prevents the development of heart failure attributable to pressure overload in mice, Circulation, 106, 2125, 10.1161/01.CIR.0000034049.61181.F3 · DOI · Paper page
  31. Fragasso, 2006, A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure, J Am Coll Cardiol, 48, 992, 10.1016/j.jacc.2006.03.060 · DOI · Paper page

Cited by

Metadata

Authors
Hirsch, G. A., Bottomley, P. A., Gerstenblith, G., & Weiss, R. G.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2012-02
Volume
59
Issue
9
Pages
802-808
ISSN
0735-1097 (ISSN-L)
OpenAlex
W2080577107
Cited by
105
References
8
FWCI
8.06
Type
journal article
Language
en
Open access
bronze
Licence
Funders
NIH (RO1-HL61912, R01-HL056332)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.